drugset / Trial / NCT04417621
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the efficacy of LXH254 combinations in previously treated unresectable or metastatic melanoma
Timeline
- Start
- 2020-10-30
- Primary completion
- 2027-02-02
- Completion
- 2027-02-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naporafenib | Small molecule | — | Oral |
| Subject | Ribociclib | Small molecule | — | Oral |
| Subject | Rineterkib | Small molecule | — | Oral |
| Subject | Trametinib | Small molecule | — | Oral |